{"doi":"10.1016/j.jinf.2021.02.002","title":"Early clinical experience with imatinib in COVID-19: Searching for a dual effect","abstract":null,"journal":"Journal of Infection","year":2021,"id":652854,"datarank":0.3958585994422889,"base_score":2.639057329615259,"endowment":2.639057329615259,"self_citation_contribution":0.3958585994422889,"citation_network_contribution":0.0,"self_endowment_contribution":0.3958585994422889,"citer_contribution":0.0,"corpus_percentile":null,"corpus_rank":null,"citation_count":13,"citer_count":0,"citers_with_citation_signal":0,"citers_with_endowment":0,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":null,"is_data_producer":false,"deposit_databanks":null,"is_oa":false,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":null,"fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":1703228,"name":"Luis Rivas-Prado","orcid":null,"position":1,"is_corresponding":false},{"id":1703229,"name":"Begoña Frutos-Pérez","orcid":null,"position":2,"is_corresponding":false},{"id":1703230,"name":"Beatriz Jaenes-Barrios","orcid":null,"position":3,"is_corresponding":false},{"id":1703231,"name":"Ana Isabel Farfán-Sedano","orcid":null,"position":4,"is_corresponding":false},{"id":1703232,"name":"Carlos Javier García-Parra","orcid":null,"position":5,"is_corresponding":false},{"id":1703233,"name":"Belén Hernández-Muniesa","orcid":null,"position":6,"is_corresponding":false},{"id":1703234,"name":"Miguel Ángel Duarte-Millán","orcid":null,"position":7,"is_corresponding":false},{"id":1703235,"name":"Elena Madroñal-Cerezo","orcid":null,"position":8,"is_corresponding":false},{"id":1703236,"name":"Ana Ontañón-Nasarre","orcid":null,"position":9,"is_corresponding":false},{"id":1703238,"name":"José Manuel Ruiz-Giardín","orcid":null,"position":10,"is_corresponding":false},{"id":1703240,"name":"Fernando Bermejo","orcid":null,"position":11,"is_corresponding":false},{"id":1703241,"name":"Mario García-Gil","orcid":null,"position":12,"is_corresponding":false},{"id":1703242,"name":"Sonia Gonzalo-Pascua","orcid":null,"position":13,"is_corresponding":false},{"id":1529722,"name":"Juan Víctor San Martín-López","orcid":"0000-0003-4457-5124","position":14,"is_corresponding":false},{"id":83437,"name":"David Bernal-Bello","orcid":null,"position":15,"is_corresponding":false},{"id":1529724,"name":"Alejandro Morales-Ortega","orcid":"0000-0002-8110-4498","position":0,"is_corresponding":false}],"reference_count":0,"raw_metadata":{"has_enrichment":true,"resolved":true,"title":"Early clinical experience with imatinib in COVID-19: Searching for a dual effect","abstract":null,"is_dataset_classified":null,"base_score":2.639057329615259,"endowment":2.639057329615259,"datacite_reuse_total":0,"file_count":0,"downloads":0,"views":0,"has_version_chain":false,"is_dataset":false,"is_oa":false,"pmid":"33549625","pmcid":"PMC7862035","openalex_id":"https://openalex.org/W3127403971","authors":[],"funders":[],"total_grants":0,"fwci":0.9531,"citation_percentile":0.71799041,"influential_citations":0,"citation_trend":[{"year":2021,"count":9},{"year":2022,"count":2},{"year":2023,"count":2}],"oa_status":"bronze","license":"https://www.elsevier.com/legal/tdmrep-license","oa_locations":[{"url":"http://www.journalofinfection.com/article/S0163445321000517/pdf","host_type":"journal"},{"url":"http://www.journalofinfection.com/article/S0163445321000517/pdf","host_type":"publisher"},{"url":"https://api.elsevier.com/content/article/PII:S0163445321000517?httpAccept=text/xml","host_type":"publisher"},{"url":"https://api.elsevier.com/content/article/PII:S0163445321000517?httpAccept=text/plain","host_type":"publisher"},{"url":"https://doi.org/10.1016/j.jinf.2021.02.002","host_type":"journal"},{"url":"https://pubmed.ncbi.nlm.nih.gov/33549625","host_type":"repository"},{"url":"http://europepmc.org/pmc/articles/PMC7862035","host_type":"repository"},{"url":"https://www.ncbi.nlm.nih.gov/pmc/articles/7862035","host_type":"repository"},{"url":"https://europepmc.org/articles/pmc7862035?pdf=render","host_type":"Unpaywall"},{"url":"https://europepmc.org/articles/PMC7862035","host_type":"Europe_PMC"},{"url":"https://europepmc.org/articles/PMC7862035?pdf=render","host_type":"Europe_PMC"}],"fields_of_study":["Immune Cell Function and Interaction","Chronic Myeloid Leukemia Treatments","Hematopoietic Stem Cell Transplantation","Amides","COVID-19","Humans","Imatinib Mesylate","Pyrazines","SARS-CoV-2","Treatment Outcome"],"mesh_terms":["Imatinib Mesylate","COVID-19","SARS-CoV-2","Amides","Humans","Pyrazines","Treatment Outcome"],"keywords":["Medicine","Imatinib","Sofosbuvir","Tyrosine-kinase inhibitor","Tyrosine kinase","Coronavirus disease 2019 (COVID-19)","Favipiravir","Nucleoside analogue","Oncology","Immunology","Internal medicine","Myeloid leukemia","Virus","Cancer","Disease","Ribavirin","Biology"],"sdg_mappings":[{"sdg_number":0,"sdg_label":"Good health and well-being"}],"linked_datasets":[],"clinical_trials":[],"software_tools":[],"database_accessions":[{"name":"nct"}],"source":"live","citation_network_status":"fetched"},"created_at":"2026-08-10T17:16:36.620067Z","pmid":null,"pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}